It was shown that the mTOR pathway is inappropriately activated in epithelial kidney cells of ADPKD patients and mouse models, suggesting a possible mechanism of pathogenic PKD1 mutations. This evidence concerns the gene MTOR and autosomal dominant polycystic kidney disease.